AimVion will be a leading company in the field of anti-inflammation drug discovery and development
AimVion is a privately held research and development company focused on peptide based drug development.
Proprietary intellectual property for a new class of anti-inflammatory peptides.
AimVion is preparing for its series A investment round.
We are continuously looking for opportunities to collaborate with scientists and industry partners.